Daou Systems wins two DoD add-on contracts

Article

Daou Systems wins two DoD add-on contractsDaou Systems has been awarded $1.6 million in additional contracts from the U.S. Department of Defense. The awards consist of a new $633,000 Military Health Services contract to develop a clinical data

Daou Systems wins two DoD add-on contracts

Daou Systems has been awarded $1.6 million in additional contracts from the U.S. Department of Defense. The awards consist of a new $633,000 Military Health Services contract to develop a clinical data standardization toolset for the DoD Health Affairs office, and $1 million in additional funds to provide continued support services for the DoD’s Composite Health Care System II project.

Under the MHS initiative, Daou will support the standardization of data elements already residing in clinical database images from legacy systems throughout the MHS. The CHCS II program is an automated medical information system that supports more than 100 military medical treatment facilities worldwide. Daou is working with Integic Corporation (formerly Universal Systems; HNN 5/17/00) on both these contracts.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.